We serve Chemical Name:(2-methyloxetan-2-yl)methanol CAS:61266-71-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(2-methyloxetan-2-yl)methanol
CAS.NO:61266-71-5
Synonyms:2-methyl-2-hydroxymethyloxetane;HT813;2-Oxetanemethanol,2-methyl;3-methyl-3-oxetanmethanol
Molecular Formula:C5H10O2
Molecular Weight:102.13200
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:29.46000
Exact Mass:102.06800
LogP:0.15770
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-methyl-2-hydroxymethyloxetane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-methyl-3-oxetanmethanol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,HT813 Use and application,2-Oxetanemethanol,2-methyl technical grade,usp/ep/jp grade.
Related News: Among them, Zhejiang pharmaceutical companies accounted for 4 of the world’s top ten API manufacturers. (2-methyloxetan-2-yl)methanol manufacturer Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms. (2-methyloxetan-2-yl)methanol supplier The iLet is designed to function as three medical devices in one. It can be configured as an insulin-only bionic pancreas, a glucagon-only bionic pancreas, or a bihormonal bionic pancreas using insulin and glucagon. (2-methyloxetan-2-yl)methanol vendor Among them, Zhejiang pharmaceutical companies accounted for 4 of the world’s top ten API manufacturers. (2-methyloxetan-2-yl)methanol factory The U.S. Food & Drug Administration on Friday said Johnson & Johnson (JNJ.N) must throw away millions of doses of its COVID-19 vaccine that were manufactured at a problem-plagued Baltimore factory but also cleared millions for use.